Genomic Responses of Human Immune and Non-Immune Cells to Glucocorticoids

NCT02798523 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

33

Enrollment

NIH

Sponsor class

Conditions

Normal Physiology

Interventions

DRUG: Methylprednisolone sodium succinate(Solu-Medrol)
DRUG: Topical methylprednisolone (Advantan emulsion 0 /1%)

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)